Postinjektionssyndrom efter behandling med olanzapin depot

Research output: Contribution to journalJournal articlepeer-review

Documents

  • Fulltext

    Final published version, 281 KB, PDF document

Treatment with olanzapine depot is associated with a rare but potentially adverse reaction, namely post-injection delirium/sedation syndrome (PDSS), characterized by delirium and/or sedation. This is a case report of a 38-year-old male patient who developed symptoms consistent with PDSS shortly after receiving intramuscular injection of olanzapine depot. Clinicians should be aware of PDSS and observe patients for three hours after receiving the injection, measuring vitals and referring to medical care if necessary.

Translated title of the contributionPost-injection delirium/sedation syndrome after treatment with olanzapine depot
Original languageDanish
Article numberV02230069
JournalUgeskrift for Laeger
Volume185
Issue number19
Number of pages4
ISSN0041-5782
Publication statusPublished - 2023

Number of downloads are based on statistics from Google Scholar and www.ku.dk


No data available

ID: 346463893